chr3-160226349-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001168214.2(C3orf80):c.714C>A(p.Asp238Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000657 in 152,154 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001168214.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
C3orf80 | NM_001168214.2 | c.714C>A | p.Asp238Glu | missense_variant | 1/1 | ENST00000326474.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
C3orf80 | ENST00000326474.5 | c.714C>A | p.Asp238Glu | missense_variant | 1/1 | NM_001168214.2 | P1 | ||
C3orf80 | ENST00000490320.2 | c.555C>A | p.Asp185Glu | missense_variant, NMD_transcript_variant | 1/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152036Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000108 AC: 1AN: 92922Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 50920
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1342064Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 659592
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152154Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74378
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 15, 2021 | The c.714C>A (p.D238E) alteration is located in exon 1 (coding exon 1) of the C3orf80 gene. This alteration results from a C to A substitution at nucleotide position 714, causing the aspartic acid (D) at amino acid position 238 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at